About | Free Trial

Last Update

2015-12-05T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Peter Glick?

Mr. Peter Glick H.

Chairman

Magellan Biosciences Inc

HQ Phone: (978) 856-2345

Email: p***@***.com

Magellan Biosciences Inc

101 Billerica Avenue Bldg. 4

North Billerica, Massachusetts 01862

United States

Company Description

History and background - Magellan Biosciences, Inc. was established in October 2004 through the combination of ESA Biosciences and Dynex Technologies - which addressed emerging growth markets in biomedical research and clinical diagnostics. In November 20 ... more

Find other employees at this company (56)

Background Information

Employment History

Chairman
Blue Sky BioServices

Venture Partner
Ampersand Ventures

General Partner
Ampersand Ventures

President and Chief Executive Officer
Cohesive Technologies Inc.

President
Primedica Corporation

Chairman
Agilux Laboratories Inc

Chairman and A Co-Founder
Agilux Laboratories Inc

Vice President of Corporate Development
Genzyme Corporation

Affiliations

Board Member
Magellan Biosciences Inc

Board Member
Blue Sky BioServices

Education

BS
Economics
The Wharton School at the University of Pennsylvania

MS
Management
MIT's Sloan School

Web References (47 Total References)


About us – Magellan Diagnostics (formerly ESA, Inc.) - LeadCare® II

www.leadcare2.com [cached]

Peter Glick, Chairman of the Board


Magellan Diagnostics

www.magellandx.com [cached]

Peter Glick, Chairman of the Board

Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, and Blue Sky Bioservices. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.


Board of Directors

www.blueskybioservices.com [cached]

Peter Glick, Chairman of the Board

Peter Glick is a venture capital investor and serial entrepreneur focused on Life Sciences, Pharma Services and CROs. In addition to Chairing Blue Sky's Board, he serves on four others, including Agilux Laboratories, where he is Chairman and a Co-Founder. He is a Venture Partner, and was previously a General Partner, at Ampersand Capital.
Peter was CEO and President of Cohesive Technologies, a venture-backed instrument and diagnostics company, and President of Primedica Corporation, a preclinical CRO. Both companies were sold in successful exits to strategic buyers.
Earlier in his career, Peter was Vice President of Corporate Development at Genzyme Transgenics and a strategy consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from the Wharton School at the University of Pennsylvania.


Magellan Diagnostics

magellandx.com [cached]

Peter Glick, Chairman of the Board

Peter is a life sciences investor and serial entrepreneur focused on clinical diagnostics, contract research organizations, and scientific instruments. He currently serves as Chairman of Magellan Diagnostics, Dynex Technologies, Agilux Laboratories, Blue Sky Bioservices, and Ekam Imaging. He is a Venture Partner at Ampersand Capital Partners, where he previously served as a General Partner.
Prior to Ampersand, he was CEO of Cohesive Technologies, a high throughput chromatography company that was acquired by Thermo Fisher, and President of Primedica Corporation, a preclinical CRO acquired by Charles River Laboratories.
Earlier in his career, Peter was VP of Corporate Development at Genzyme Transgenics Corporation, and a management consultant at Bain & Company. He holds an MS in Management from MIT's Sloan School and a BS in Economics from The Wharton School at the University of Pennsylvania.


Magellan

www.magellanbio.com [cached]

Peter H. Glick - Ampersand Ventures General Partner (private equity investments)

Similar Profiles

Other People with this Name

Other people with the name Glick

Shay Glick
Fischer Behar Chen & Co

Susan Glick
Fashion Group International Inc

Jacqueline Glick
Beneficial Savings Bank

Jennifer Glick
National IT Staffing

Philip Glick

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory